thyssenkrupp nucera AG & Co. KGaA — Cyborg Score 7/10
Solid
Industrial Electrolysis Technology & Green Hydrogen Solutions
Strategic Profile
The company has demonstrated 43% revenue CAGR over two years with a projected 29% CAGR through 2029. Wall Street analysts project a 12-month price target of €18.71 EUR compared to recent trading around €9.16 EUR. Q4 2025 results showed mixed signals: 2% YoY revenue decline while EBIT improved; green hydrogen segment sales fell 12% but chlor-alkali achieved record 14% growth.
Cyborg Score Rationale
Analyst consensus projects 110% upside potential to €18.71 from current €9.16 pricing. Strong projected growth (29% revenue CAGR, 41% operating income CAGR, 24% net income CAGR) through 2029 is tempered by near-term headwinds in green hydrogen markets and execution risks.
Top Insights
43% historical revenue CAGR with 29% projected growth through 2029 reflects strong secular tailwinds in green hydrogen and industrial decarbonization
Chlor-alkali segment posted record 14% growth in Q4 2025, providing revenue diversification beyond volatile green hydrogen markets